Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Kathleen Marie Powis, M.D.

Co-Author

This page shows the publications co-authored by Kathleen Powis and Shahin Lockman.
Connection Strength

4.275
  1. Factors Associated with Infant Feeding Choices Among Women with HIV in Botswana. Matern Child Health J. 2021 Sep; 25(9):1376-1391.
    View in: PubMed
    Score: 0.227
  2. Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment. Open Forum Infect Dis. 2020 Oct; 7(10):ofaa373.
    View in: PubMed
    Score: 0.216
  3. Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy. South Afr J HIV Med. 2020; 21(1):1023.
    View in: PubMed
    Score: 0.208
  4. In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana. Pediatr Infect Dis J. 2019 08; 38(8):828-834.
    View in: PubMed
    Score: 0.201
  5. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. N Engl J Med. 2019 07 18; 381(3):230-242.
    View in: PubMed
    Score: 0.200
  6. Self-reported risky sexual practices among adolescents and young adults in Botswana. South Afr J HIV Med. 2019; 20(1):899.
    View in: PubMed
    Score: 0.200
  7. Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana. South Afr J HIV Med. 2018; 19(1):751.
    View in: PubMed
    Score: 0.183
  8. Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana. J Int AIDS Soc. 2017 11; 20(3).
    View in: PubMed
    Score: 0.178
  9. Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana. PLoS One. 2017; 12(3):e0173800.
    View in: PubMed
    Score: 0.171
  10. Hidden in plain sight: HIV, antiretrovirals, and stillbirths. Lancet. 2016 May 14; 387(10032):1994-5.
    View in: PubMed
    Score: 0.161
  11. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. AIDS. 2016 Jan; 30(2):211-20.
    View in: PubMed
    Score: 0.157
  12. Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana. Pediatr Infect Dis J. 2014 Nov; 33(11):1141-7.
    View in: PubMed
    Score: 0.145
  13. Single-arm evaluation of the AccuCirc device for early infant male circumcision in Botswana. J Acquir Immune Defic Syndr. 2014 May 01; 66(1):1-6.
    View in: PubMed
    Score: 0.140
  14. Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants. PLoS One. 2013; 8(9):e74171.
    View in: PubMed
    Score: 0.134
  15. A randomized trial of Mogen clamp versus Plastibell for neonatal male circumcision in Botswana. J Acquir Immune Defic Syndr. 2013 Apr 15; 62(5):e131-7.
    View in: PubMed
    Score: 0.130
  16. High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana. J Acquir Immune Defic Syndr. 2013 Apr 15; 62(5):517-24.
    View in: PubMed
    Score: 0.130
  17. Loss of anatomical landmarks with eutectic mixture of local anesthetic cream for neonatal male circumcision. J Pediatr Urol. 2013 Feb; 9(1):e86-90.
    View in: PubMed
    Score: 0.126
  18. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011 Aug 15; 204(4):506-14.
    View in: PubMed
    Score: 0.116
  19. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr. 2011 Apr 15; 56(5):428-36.
    View in: PubMed
    Score: 0.113
  20. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr. 2011 Feb 01; 56(2):131-8.
    View in: PubMed
    Score: 0.112
  21. Immune correlates of HIV-1 reservoir cell decline in early-treated infants. Cell Rep. 2022 Jul 19; 40(3):111126.
    View in: PubMed
    Score: 0.062
  22. Prolonged Cotrimoxazole Prophylaxis Has No Impact on Child Growth in the First Two Years of Life: Findings from a Randomized Controlled Trial in Botswana. J Pediatr. 2022 07; 246:266-270.e2.
    View in: PubMed
    Score: 0.060
  23. Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in Botswana. BMC Med Res Methodol. 2021 10 17; 21(1):212.
    View in: PubMed
    Score: 0.059
  24. Modest reduction in adverse birth outcomes following the COVID-19 lockdown. Am J Obstet Gynecol. 2021 06; 224(6):615.e1-615.e12.
    View in: PubMed
    Score: 0.055
  25. Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines. PLoS One. 2020; 15(12):e0244100.
    View in: PubMed
    Score: 0.055
  26. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana. PLoS One. 2020; 15(8):e0237252.
    View in: PubMed
    Score: 0.054
  27. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. Lancet HIV. 2020 06; 7(6):e422-e433.
    View in: PubMed
    Score: 0.053
  28. Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile. Sci Transl Med. 2019 11 27; 11(520).
    View in: PubMed
    Score: 0.051
  29. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015. PLoS One. 2018; 13(10):e0204840.
    View in: PubMed
    Score: 0.048
  30. Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana. J Acquir Immune Defic Syndr. 2018 08 15; 78(5):557-565.
    View in: PubMed
    Score: 0.047
  31. Undisclosed antiretroviral drug use in Botswana: implication for national estimates. AIDS. 2018 07 17; 32(11):1543-1546.
    View in: PubMed
    Score: 0.047
  32. High HIV-1 RNA Among Newly Diagnosed People in Botswana. AIDS Res Hum Retroviruses. 2018 03; 34(3):300-306.
    View in: PubMed
    Score: 0.045
  33. High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy. AIDS Patient Care STDS. 2017 Jan; 31(1):14-19.
    View in: PubMed
    Score: 0.042
  34. Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable. J Clin Microbiol. 2016 12; 54(12):3050-3055.
    View in: PubMed
    Score: 0.041
  35. HIV-exposed children account for more than half of 24-month mortality in Botswana. BMC Pediatr. 2016 07 21; 16:103.
    View in: PubMed
    Score: 0.041
  36. Predictors of early breastfeeding cessation among HIV-infected women in Botswana. Trop Med Int Health. 2016 Aug; 21(8):1013-1018.
    View in: PubMed
    Score: 0.040
  37. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV. 2016 May; 3(5):e221-30.
    View in: PubMed
    Score: 0.040
  38. Risk factors for mortality among human immunodeficiency virus-exposed and unexposed infants admitted to a neonatal intensive care unit in Botswana. J Paediatr Child Health. 2014 Mar; 50(3):189-95.
    View in: PubMed
    Score: 0.034
  39. No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):572-7.
    View in: PubMed
    Score: 0.033
  40. HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana. AIDS. 2013 Jul 31; 27(12):1911-20.
    View in: PubMed
    Score: 0.033
  41. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis. 2012 Dec 01; 206(11):1695-705.
    View in: PubMed
    Score: 0.031
  42. High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana. PLoS One. 2012; 7(2):e31580.
    View in: PubMed
    Score: 0.030
  43. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010 Jun 17; 362(24):2282-94.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.